APA (7th ed.) Citation

Yan, Y., Huang, Z., Zhu, Z., Wang, Y., Cao, X., Yang, C., . . . Shen, B. IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer. BMC.

Chicago Style (17th ed.) Citation

Yan, Yilin, Zhengnan Huang, Zhen Zhu, Yang Wang, Xiangqian Cao, Chenkai Yang, Junfeng Jiang, Shujie Xia, and Bing Shen. IMP2 Drives Chemoresistance by Repressing Cisplatin-induced Apoptosis and Ferroptosis via Activation of IPO4 and SLC7A11 Under Hypoxia in Bladder Cancer. BMC.

MLA (9th ed.) Citation

Yan, Yilin, et al. IMP2 Drives Chemoresistance by Repressing Cisplatin-induced Apoptosis and Ferroptosis via Activation of IPO4 and SLC7A11 Under Hypoxia in Bladder Cancer. BMC.